What are the Sequence Rules in patent applications?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30

This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice.

The Sequence Rules are a set of regulations that define how nucleotide and amino acid sequences must be presented in patent applications. According to MPEP 2421.02, these rules “define a set of symbols and procedures that are both mandatory and the only way that an applicant is permitted to describe information in the ‘Sequence Listing’ about a nucleotide or amino acid sequence that falls within the definitions used in the rules.”

Key points about the Sequence Rules include:

  • They define what constitutes a “sequence” and a “Sequence Listing”
  • They specify requirements for symbols and formats in the Sequence Listing
  • They mandate the submission of a computer readable form (CRF) of the Sequence Listing
  • They set deadlines for compliance

It’s important to note that these rules are mandatory and must be followed precisely when submitting sequence information in patent applications.

Topics: MPEP 2400 - Biotechnology MPEP 2421.02 - Summary Of The Requirements Of The Sequence Rules Patent Law Patent Procedure
Tags: Sequence Format